kle ec cells (Servicebio Inc)
Structured Review

Kle Ec Cells, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kle+ec+cells/cells+ec+kle/pmc12753587-23-8-12
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "PTBP1 functions as a suppressor of ferroptosis in endometrial carcinoma cells by stabilizing SLC7A11 mRNA"
Article Title: PTBP1 functions as a suppressor of ferroptosis in endometrial carcinoma cells by stabilizing SLC7A11 mRNA
Journal: Discover Oncology
doi: 10.1007/s12672-025-04128-0
Figure Legend Snippet: In vitro functional analysis of PTBP1 in endometrial cancer cells and in vivo validation using an Ishikawa xenograft model. A and B Transfection with shRNA knockdown vectors targeting PTBP1 significantly reduced both mRNA and protein levels in Ishikawa and KLE cell lines. C PTBP1 knockdown notably decreased cell viability in both Ishikawa and KLE cells. D – H Cell-derived xenograft (CDX) experiments in mice implanted with Ishikawa cells demonstrated that PTBP1 knockdown significantly reduced tumor volume and weight. Subsequent IHC staining of the xenograft tissues revealed a substantial decrease in Ki-67 protein levels and increase in 4-HNE level upon PTBP1 knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001
Techniques Used: In Vitro, Functional Assay, In Vivo, Biomarker Discovery, Transfection, shRNA, Knockdown, Derivative Assay, Immunohistochemistry
Figure Legend Snippet: PTBP1 knockdown facilitates ferroptosis in endometrial cancer cells. A Measurement of ROS production using DCF-DA probes. B GSH, C MDA, and D Fe 2+ levels in Ishikawa and KLE EC cells transfected with PTBP1-shRNA (shPTBP1) or nontargeting control (shNC) vectors, measured by relevant assay kits. E– I Ishikawa and KLE EC cells transfected with shPTBP1 or shNC for 48 h were analyzed for mRNA expression of ACSL4 ( E ) and GPX4 ( F ), by RT-qPCR, as well as protein expression of ACSL4 ( G and H ) by Western blot, and GPX4 ( I ) by immunofluorescence. J and K The mRNA expression of SLC7A11 ( J ), as well as protein expression of SLC7A11, ACSL4, and GPX4 ( K ) in mice tumor tissues were determined by RT-qPCR and western blot assays. L The protein level of HSP27 in mice tumor tissues was tested by IHC. M Cell viability of Ishikawa and KLE cells transduced with shNC or shPTBP1 and treated with DMSO, Erastin (10 µM), or Erastin plus Ferrostatin-1 (Fer-1, 1 µM) for 24 h, measured by CCK-8 assay. * p < 0.05, ** p < 0.01, *** p < 0.001
Techniques Used: Knockdown, Transfection, shRNA, Control, Expressing, Quantitative RT-PCR, Western Blot, Immunofluorescence, Transduction, CCK-8 Assay
Figure Legend Snippet: PTBP1 mediates SLC7A11 mRNA stability by binding to its 5’UTR. A Venn diagram displaying the overlap between differentially expressed genes (DEGs) (using criteria of p -adj < 0.05 and |log 2 FoldChange| >0.58) in PTBP1-KD Ishikawa EC cells versus shNC controls, ferroptosis-related genes, and predicted PTBP1 targets identified by the StarBase algorithm. B Transcriptomic analysis of TCGA revealed the mRNA expression levels of SLC7A11 and CBS in EC tissues compared to normal tissues. C Quantitative PCR analysis showing enrichment of SLC7A11 mRNA in anti-PTBP1 immunoprecipitates compared to anti-IgG controls. D Schematic representation of the SLC7A11 5’UTR, the predicted PTBP1 binding site (WT), and the mutated binding site (MUT). E Relative luciferase activity of WT or MUT reporters in shPTBP1- or shNC-transfected 293T cells. F DNA pull down-western blot showing PTBP1 enrichment in Bio-SLC7A11 5’UTR pull-downs compared to Bio-NC controls. G and H Quantification of SLC7A11 mRNA in shPTBP1- or shNC-transfected Ishikawa and KLE cells. I and J mRNA stability analysis using the actinomycin D exposure method, with RNA collected at 0, 1, 2, 3, and 4 h after exposure and quantified by PCR. K and L Measurement of SLC7A11 protein levels in PTBP1 KD and control Ishikawa and KLE cells. * p < 0.05, ** p < 0.01, *** p < 0.001, n.s. non-significant
Techniques Used: Binding Assay, Expressing, Real-time Polymerase Chain Reaction, Luciferase, Activity Assay, Transfection, Western Blot, Control
Figure Legend Snippet: PTBP1 disruption induces ferroptosis through downregulation of SLC7A11. A – F Western blot analysis of SLC7A11 protein ( A ), CCK8 assay for cell viability ( B ), ROS production measured using DCFH-DA probes and fluorescence analysis ( C ), GSH content ( D ), MDA expression ( E ), and Fe2 + levels ( F ) in Ishikawa and KLE EC cells transfected with shPTBP1, shPTBP1 + SLC7A11-ov, shPTBP1 + vec, or nontargeting control shNC. * p < 0.05, ** p < 0.01, *** p < 0.001
Techniques Used: Disruption, Western Blot, CCK-8 Assay, Fluorescence, Expressing, Transfection, Control
Figure Legend Snippet: Knockdown of SLC7A11 alone is sufficient to induce ferroptosis in endometrial cancer cells. A Western blot analysis validating the knockdown efficiency of SLC7A11 in Ishikawa and KLE cells transfected with shSLC7A11 or shNC. B Cell viability measured by CCK-8 assay in Ishikawa and KLE cells after SLC7A11 knockdown . C and D Intracellular ROS levels detected by DCFH-DA fluorescence in Ishikawa and KLE cells after SLC7A11 knockdown. E – G Assessment of key ferroptosis biochemical markers in Ishikawa and KLE cells after SLC7A11 knockdown, including E glutathione (GSH) levels, F malondialdehyde (MDA) content, and G ferrous iron (Fe 2+ ) concentration. ** p < 0.01, *** p < 0.001
Techniques Used: Knockdown, Western Blot, Transfection, CCK-8 Assay, Fluorescence, Concentration Assay
Related Articles
Cell Culture:Article Title: PTBP1 functions as a suppressor of ferroptosis in endometrial carcinoma cells by stabilizing SLC7A11 mRNA Article Snippet: .. Ishikawa EC cells (#CL-0823, Procell, Wuhan, China) and Modification:Article Title: PTBP1 functions as a suppressor of ferroptosis in endometrial carcinoma cells by stabilizing SLC7A11 mRNA Article Snippet: .. Ishikawa EC cells (#CL-0823, Procell, Wuhan, China) and |

